Assessment of Cognitive Impairment in Older Research Participants

Abstract

In any clinical trial or observational study, a certain level of cognitive function is required in order to ensure participant safety and ability to comply with the study protocol. Participants should adequately understand what is involved in their participation, as well as any potential risks or benefits of participation. The costs of using a specific screening method, however, need to be weighed against the information obtained. This prevents the inefficient use of available resources, such as avoiding assessments that require an extremely long administration time and unnecessarily increase participant burden. Due to the inherent challenges in obtaining a valid assessment of cognitive function in a time efficient manner, all potential assessment measures should be evaluated with a “best fit” approach. Keeping this “best fit” approach in mind, we reviewed and evaluated a number of screening tests for assessing cognitive impairment based on recommendations provided by experts in the field. Based on our review, we provide recommendations about existing methods for screening cognitive function in older research participants. Using the “best fit” approach, we would recommend the Mini-Mental State Examination (MMSE) to screen for cognitive impairment in older research participants. Other measures, such as the Cognitive Abilities Screening Instrument (CASI) and Modified Mini-Mental State (3MS), are indeed promising, but the MMSE can be administered in a time efficient manner and has the highest amount of supporting literature.In any clinical trial or observational study, a certain level of cognitive function is required in order to ensure participant safety and ability to comply with the study protocol. Participants should adequately understand what is involved in their participation, as well as any potential risks or benefits of participation. Although studies involving simple surveys or questionnaires may not require as careful screening as potentially higher risk studies(e.g., pharmacological interventions), [1] it is always necessary to ensure the participant fully understands the potential risks involved before agreeing to participate in the study. Age has been found to be significantly associated with cognitive decline [2,3] thus cognitive function and understanding of study risks and procedures should be carefully assessed in studies involving adults who are 60 years and older [4]. Careful assessment of cognitive function in older research participants, as well as screening for mild cognitive impairment, could help to prevent incidents such as an accidental overdose resulting from a previously forgotten dose being taken. Ensuring that the participant is capable of adhering to study protocols can prevent inappropriate requirements from being placed on the participant. Additionally, screening for cognitive impairment benefits the scientific community at large; ensuring that participants fully understand what they are agreeing to is vital for ethically sound science.

Authors and Affiliations

Robbie Ingram, Robert Fieo, Stephen D Anton

Keywords

Related Articles

Quantification and Modeling of Biological Processes for Tissue Engineering and Regenerative Medicine

Too often research papers that claim to be designing a better clinical treatment, in tissue engineering/ regenerative medicine, use the scientific method to prove that the new design gives a statistically significant dif...

Analysis of the Evaporation to Sublimation Phase Transition during Minimal Invasive Surgery Procedures via Pulsed CO2 lasers

Objective This Paper describes a mathematical approach to quantify the phase transition from ablation to evaporation of PMMA irradiated by pulsed CO2 laser devices to be used as reference data for Ultra-Conservative Mini...

Creating a Healthier Nation through Public Health Genetics

The US Surgeon General Family History Initiative is a powerful tool enabling individuals of the general population to engage in preventive health care as they proactively make well informed decisions regarding the qualit...

Human Reproduction: Target of Endocrine Disruptors

Endocrine disruptors are natural or man-made hormone-like molecules, which after entering into the human organism are bound by hormone receptors (similarly to physiological hormones) disturbing the normal (endogenous) ho...

Vitamin D Receptor Gene TAQ 1 (rs 731236) PolymorphismIn Breast Cancer Patients ATH Adam Malik Hospital Medan and its Relationship with Histopathologygrading

Background: Breast cancer is the one of major cause of death in women especially in developing countries. In 2012 it was recorded nearly 522.000 deaths occurred due to this cancer. Taq 1 polymorphism is a silent SNPs cal...

Download PDF file
  • EP ID EP572784
  • DOI 10.26717/BJSTR.2017.01.000316
  • Views 161
  • Downloads 0

How To Cite

Robbie Ingram, Robert Fieo, Stephen D Anton (2017). Assessment of Cognitive Impairment in Older Research Participants. Biomedical Journal of Scientific & Technical Research (BJSTR), 1(3), 842-846. https://europub.co.uk/articles/-A-572784